Our mission is to care and cure.

We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.

Research Grants 436 show all


$48M
2016

$108.6M
2017

$206.1M
2018

$155.2M
2019

$14M
2020

Publications 287 show all

  • 14
    Aldehyde Reductase/antagonists & inhibitors
  • 10
    Lenses, Intraocular
  • 9
    Contact Lenses, Hydrophilic
  • 7
    Hydantoins/pharmacokinetics
  • 7
    Intraocular Pressure/drug effects
  • 7
    Lens, Crystalline/metabolism
  • 7
    Sugar Alcohol Dehydrogenases/antagonists & inhibitors
  • 6
    Cornea/metabolism
  • 6
    Fluorenes/pharmacokinetics
  • 6
    Histamine H1 Antagonists/pharmacology

Patents 145,621show all

  • 22,067
    C07D - Heterocyclic compounds
  • 17,344
    A61K - Preparations for medical, dental, or toilet purposes
  • 9,213
    C07C - Acyclic or carbocyclic compounds
  • 7,658
    A01N - Preservation of bodies of humans or animals or plants or parts thereof
  • 7,159
    C09B - Organic dyes or closely-related compounds for producing dyes
  • 5,466
    C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients
  • 5,267
    C07K - Peptides
  • 5,004
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 4,916
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 3,412
    C12N - Microorganisms or enzymes

Clinical Trials 5,816show all

1,654Phase 21,640Phase 3770Phase 4610Phase 1597N/A351Other

Contact Information

Basel, NY
Switzerland